• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SD filed by Becton Dickinson and Company

    5/28/25 6:05:23 AM ET
    $BDX
    Medical/Dental Instruments
    Health Care
    Get the next $BDX alert in real time by email
    SD 1 d12156dsd.htm SD SD
     
     

    United States

    Securities and Exchange Commission

    Washington, D.C. 20549

     

     

    FORM SD

     

     

    SPECIALIZED DISCLOSURE REPORT

     

     

    Becton, Dickinson and Company

    (Exact name of registrant as specified in its charter)

     

     

     

    New Jersey   001-4802   22-0760120

    (State or other jurisdiction of

    incorporation or organization)

     

    (Commission

    File Number)

     

    (IRS Employer

    Identification No.)

     

    1 Becton Drive

    Franklin Lakes, New Jersey

      07417-1880
    (Address of principal executive offices)   (Zip Code)

    Maureen Mazurek

    (314) 3781251

    (Name and telephone number, including area code, of the person to contact in connection with this report.)

     

     

    Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:

     

    ☒

    Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2024

     

     
     


    Section 1 – Conflict Minerals Disclosure

     

    Item 1.01

    Conflict Minerals Disclosure and Report

    As contemplated by Rule 13p-1 under the Securities Exchange Act of 1934, as amended, and Form SD, a Conflict Minerals Report is provided as an Exhibit to this Form SD and is available at the following Internet website: https://investors.bd.com/financial-information/sec-filings. The information contained on our website is not incorporated by reference into this Form SD or our Conflict Minerals Report and should not be considered part of this Form SD or the Conflict Minerals Report.

    Information concerning tin, tantalum, tungsten, or gold from recycled or scrap sources that may be contained in our in-scope products is included in the Conflict Minerals Report and is incorporated in this Form SD by reference.

     

    Item 1.02

    Exhibit

    The Conflict Minerals Report contemplated by Item 1.01 is filed as Exhibit 1.01 to this Form SD.

    Section 2 – Exhibits

     

    Item 2.01

    Exhibits

    Exhibit 1.01 – Conflict Minerals Report for the calendar year ended December 31,2024.


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.

    Becton, Dickinson and Company

    (Registrant)

     

    By:  

    David Shan

          May 27th, 2025
    Name:   David Shan      
    Title:   Executive Vice President, Chief Integrated Supply Chain Officer      


    EXHIBIT INDEX

     

    Exhibit

      

    Description

    1.01    Conflict Minerals Report for the calendar year ended December 31,2024.
    Get the next $BDX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BDX

    DatePrice TargetRatingAnalyst
    5/22/2025$185.00Buy → Neutral
    Citigroup
    5/2/2025$185.00Overweight → Neutral
    Piper Sandler
    5/2/2025$192.00Buy → Neutral
    Goldman
    5/2/2025Outperform → Mkt Perform
    Raymond James
    5/1/2025Overweight → Equal Weight
    Wells Fargo
    5/1/2025$190.00Buy → Neutral
    BofA Securities
    5/1/2025Outperform → Mkt Perform
    William Blair
    10/1/2024$255.00 → $275.00Neutral → Buy
    Citigroup
    More analyst ratings